Effects of phenobarbitone con serum biochemical tests in dogs

Citation
Sf. Foster et al., Effects of phenobarbitone con serum biochemical tests in dogs, AUST VET J, 78(1), 2000, pp. 23-26
Citations number
24
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
AUSTRALIAN VETERINARY JOURNAL
ISSN journal
00050423 → ACNP
Volume
78
Issue
1
Year of publication
2000
Pages
23 - 26
Database
ISI
SICI code
0005-0423(200001)78:1<23:EOPCSB>2.0.ZU;2-#
Abstract
Objectives To investigate effects of phenobarbitone on serum activities of alanine aminotransferase, alkaline phosphatase and gamma-glutamyl transfera se and concentrations of bilirubin, albumin, cholesterol and total protein in dogs. Animals Ten crossbreed experimental clogs and 10 client-owned dogs of mixed breeds treated chronically with phenobarbitone to control seizures. Procedures Experimental dogs were allocated to treatment (6 mg/kg oral phen obarbitone, n = 6) and control (no treatment, n = 4) groups in which serum biochemical tests were performed at intervals during a 3-month period. Bioc hemical tests were performed once on the 10 epileptic dogs. Results Phenobarbitone caused increased serum alkaline phosphatase activity but did not affect gammaglutamyl transferase activity or bilirubin, choles terol, albumin and total protein concentrations. Phenobarbitone had minimal effect on alanine aminotransferase activity. Conclusions Individual dogs treated with phenobarbitone may have small incr eases in serum alanine aminotransferase activity and variable increases in alkaline phosphatase activity but are unlikely to have alterations in gamma -glutamyl transferase activity or bilirubin, cholesterol, albumin or total protein concentrations.